Phentolamine Mesylate

CAS 65-28-1 5 current records 1 historicalSmall Molecule

Who holds supplier records for Phentolamine Mesylate? 5 organisations hold a current record for Phentolamine Mesylate: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1), Italy (1), China (1) and United States (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Phentolamine Mesylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/phentolamine-mesylate

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Phentolamine Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India1Italy1China1United States1Country not recorded for 1
  • MATRIX PHARMACORP PRIVATE LTD
    Active DMF 28193, 42112 · latest filing Jun 2025
    India
  • APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC)
    Active DMF 39948 · latest filing Jun 2024
  • INDUSTRIALE CHIMICA SRL
    Active DMF 16428 · latest filing Feb 2003
    Italy Company GMP cert on record
  • Jiangsu Lianhuan Pharmaceutical Co.,Ltd.
    Active DMF 39578 · latest filing Mar 2024
    China
  • RELIABLE BIOPHARMACEUTICAL CORP
    Active DMF 12260 · latest filing Dec 1996
    United States
Need Phentolamine Mesylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Phentolamine Mesylate are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • SYNKEM DIV PLASTO SA
    Inactive DMF 11936 · filed Apr 1996

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Phentolamine mesylate is a non-selective alpha-adrenergic antagonist used to manage hypertension, particularly in pheochromocytoma cases. It is also utilized in reversing soft-tissue anesthesia after dental procedures.

Chemical identity

IUPAC name
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid
Canonical SMILES
CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O
InChIKey
OGIYDFVHFQEFKQ-UHFFFAOYSA-N
Synonyms
Regitine API, mesylate phentolamine, mesilate phentolamine, nv-101, oraverse, phentolamine mesilate, phentolamine methanesulfonate, regitine, ryzumvi

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
alpha-Adrenergic Blocker
Mechanism of action
Adrenergic alpha-Antagonists

Therapeutic areas

CardiovascularUrologyEndocrinology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Phentolamine Mesylate?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Phentolamine Mesylate: MATRIX PHARMACORP PRIVATE LTD (India), APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC), INDUSTRIALE CHIMICA SRL (Italy), Jiangsu Lianhuan Pharmaceutical Co.,Ltd. (China) and RELIABLE BIOPHARMACEUTICAL CORP (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Phentolamine Mesylate Drug Master Files are active?

MATRIX PHARMACORP PRIVATE LTD (DMF 28193, 42112), APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC) (DMF 39948), INDUSTRIALE CHIMICA SRL (DMF 16428), Jiangsu Lianhuan Pharmaceutical Co.,Ltd. (DMF 39578) and RELIABLE BIOPHARMACEUTICAL CORP (DMF 12260). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Phentolamine Mesylate records mean?

1 organisation has only inactive Type II DMFs for Phentolamine Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Phentolamine Mesylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Phentolamine Mesylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.